These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35757591)

  • 1. Inference for partially observed competing risks model for Kumaraswamy distribution under generalized progressive hybrid censoring.
    Mahto AK; Lodhi C; Tripathi YM; Wang L
    J Appl Stat; 2022; 49(8):2064-2092. PubMed ID: 35757591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inference of progressively type-II censored competing risks data from Chen distribution with an application.
    Ahmed EA; Ali Alhussain Z; Salah MM; Haj Ahmed H; Eliwa MS
    J Appl Stat; 2020; 47(13-15):2492-2524. PubMed ID: 35707419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parametric inference on partially accelerated life testing for the inverted Kumaraswamy distribution based on Type-II progressive censoring data.
    Yousef MM; Alsultan R; Nassr SG
    Math Biosci Eng; 2023 Jan; 20(2):1674-1694. PubMed ID: 36899503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inference on a progressive type I interval-censored truncated normal distribution.
    Lodhi C; Tripathi YM
    J Appl Stat; 2020; 47(8):1402-1422. PubMed ID: 35706702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal sampling and statistical inferences for Kumaraswamy distribution under progressive Type-II censoring schemes.
    Abo-Kasem OE; El Saeed AR; El Sayed AI
    Sci Rep; 2023 Jul; 13(1):12063. PubMed ID: 37495654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian Inference for the Kumaraswamy Distribution under Generalized Progressive Hybrid Censoring.
    Tu J; Gui W
    Entropy (Basel); 2020 Sep; 22(9):. PubMed ID: 33286799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimations of competing lifetime data from inverse Weibull distribution under adaptive progressively hybrid censored.
    Azm WSAE; Aldallal R; Aljohani HM; Nassr SG
    Math Biosci Eng; 2022 Apr; 19(6):6252-6275. PubMed ID: 35603400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inference for Inverse Power Lomax Distribution with Progressive First-Failure Censoring.
    Shi X; Shi Y
    Entropy (Basel); 2021 Aug; 23(9):. PubMed ID: 34573724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation and prediction for Burr type III distribution based on unified progressive hybrid censoring scheme.
    Dutta S; Kayal S
    J Appl Stat; 2024; 51(1):1-33. PubMed ID: 38179163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical inference for Nadarajah-Haghighi distribution under unified hybrid censored competing risks data.
    Abushal TA
    Heliyon; 2024 Mar; 10(5):e26794. PubMed ID: 38562494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical Inference of Truncated Normal Distribution Based on the Generalized Progressive Hybrid Censoring.
    Zeng X; Gui W
    Entropy (Basel); 2021 Feb; 23(2):. PubMed ID: 33540595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian and maximum likelihood estimations of the Dagum parameters under combined-unified hybrid censoring.
    Emam W; S Sultan K
    Math Biosci Eng; 2021 Mar; 18(3):2930-2951. PubMed ID: 33892578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical inference for a constant-stress partially accelerated life tests based on progressively hybrid censored samples from inverted Kumaraswamy distribution.
    Yousef MM; Alyami SA; Hashem AF
    PLoS One; 2022; 17(8):e0272378. PubMed ID: 35913958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of interval-censored competing risks data under missing causes.
    Mitra D; Das U; Das K
    J Appl Stat; 2020; 47(3):439-459. PubMed ID: 35706970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian estimation for Dagum distribution based on progressive type I interval censoring.
    Alotaibi R; Rezk H; Dey S; Okasha H
    PLoS One; 2021; 16(6):e0252556. PubMed ID: 34077455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimations of Generalized Exponential Distribution Parameters Based on Type I Generalized Progressive Hybrid Censored Data.
    Nagy M; Alrasheedi AF
    Comput Math Methods Med; 2022; 2022():8058473. PubMed ID: 35392586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competing risks survival data under middle censoring-An application to COVID-19 pandemic.
    Rehman H; Chandra N; Jammalamadaka SR
    Healthc Anal (N Y); 2021 Nov; 1():100006. PubMed ID: 38620911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inference on Nadarajah-Haghighi distribution with constant stress partially accelerated life tests under progressive type-II censoring.
    Dey S; Wang L; Nassar M
    J Appl Stat; 2022; 49(11):2891-2912. PubMed ID: 36093036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical inference with joint progressive censoring for two populations using power Rayleigh lifetime distribution.
    Tolba AH; Abushal TA; Ramadan DA
    Sci Rep; 2023 Mar; 13(1):3832. PubMed ID: 36882479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classical and Bayesian Inference of an Exponentiated Half-Logistic Distribution under Adaptive Type II Progressive Censoring.
    Xiong Z; Gui W
    Entropy (Basel); 2021 Nov; 23(12):. PubMed ID: 34945864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.